<DOC>
	<DOCNO>NCT00288236</DOCNO>
	<brief_summary>Primary : Effect HbA1c 48 week insulin-treated patient type 2 diabetes Secondary : Effect glucose , total daily insulin dose , body weight , waist circumference , HDL-cholesterol , triglycerides - Safety , tolerability</brief_summary>
	<brief_title>Study Evaluating Rimonabant Efficacy Insulin-Treated Diabetic Patients ( ARPEGGIO )</brief_title>
	<detailed_description>The total duration study 360 day include screening period ( 14 day ) double-blind treatment period ( approximately 11 month ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rimonabant</mesh_term>
	<criteria>Male female patient age great equal 18 year . Diagnosis type 2 diabetes define WHO criterion . Type 2 diabetes treat insulin least 3 month ( insulin dose least 30 U/day least 4 week ) . HbA1C great equal 7 % . Having sign informed consent form . General : Weight loss &gt; 5 kg within 3 month prior screen visit . Pregnancy lactation . Absence medically approve contraceptive method female childbearing potential . Administration investigational drug within 30 day prior screen visit . Previous participation Rimonabant study . Presence history allergic reaction intolerance multiple drug . Related endocrine metabolic disorder : Presence clinically significant endocrine disease accord Investigator.Note : euthyroid patient replacement therapy include dosage thyroxine stable least 3 month prior screen visit . Fasting Cpeptide &lt; 1.0 ng/mL . Related disorder : Presence severe medical psychological condition opinion Investigator would compromise patient 's safety successful participation study . Presence history cancer within past 5 year exception adequately treat localized basal cell skin cancer situ uterine cervical cancer . Related laboratory finding : Positive test hepatitis B surface antigen and/or hepatitis C antibody . Abnormal TSH level ( TSH &gt; ULN &lt; LLN ) . Positive urine pregnancy test . Related previous concomitant medication : Antidiabetic drug insulin within 3 month prior screen visit . Drugs affect weight ( e.g. , sibutramine , orlistat , herbal preparation , etc ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
</DOC>